Healthcare

Clinical Trials / Studies

Master
Content

Clinical trials - also known as clinical studies or research protocols - are conducted to test whether a new drug, new prevention strategy, or new screening test is safe and effective in people. Participation is always voluntary. Baylor College of Medicine investigators conduct hundreds of studies, ranging from small, short-term studies to large trials with thousands of patients across many institutions.

Content

View Actively Recruiting Studies at Baylor College of Medicine trials on ClinicalTrials.gov.

Search for Clinical Trials

The purpose of this study is to collect information on breast reconstruction surgeries to determine the effect of neurotization of autologous tissue…
  • Cancer - Breast
A Prospective, Multi-Center, Randomized, Double-Arm Trial To Determine The Impact Of The SELENE System On Positive Margin Rates In Breast…
  • Cancer - Breast
Introduction: Comorbidities pose significant challenges to the delivery of quality cancer treatment. Medically underserved patients have the highest…
  • Cancer - Breast
  • Cancer - Gastric/Stomach
  • Cancer - Colon/Rectal
  • Cancer - Hematology
  • Cancer - Liver
  • Cancer - Pancreas
This study is a first in human Phase 1 study that involves patients with a type of cancer called HER2 (Human Epidermal Growth Factor Receptor 2)…
  • Cancer - Breast
  • Cancer - Head/Neck
  • Cancer - Gastric/Stomach
  • Cancer - Esophagus
  • Cancer - Colon/Rectal
  • Cancer - Bladder
  • Cancer - All
  • Cancer - Pancreas
  • Cancer - Lung
The main purpose of this study is to look at the safety and effectiveness of the standard anti-HER2-targeted therapies.
  • Cancer - Breast
A study to determine if the combination of avelumab with several different drugs is safe and effective for treating patients with metastatic triple-…
  • Cancer - Breast
  • Cancer - Metastatic
This study is to find out if patients with HER2-positive breast cancer who have no cancer remaining at surgery after 12 weeks of chemotherapy and 2…
  • Cancer - Breast
This study is being done to find out if tucatinib plus T-DM1 works better to treat breast cancer than T-DM1 alone. Tucatinib is a type of drug…
  • Cancer - Breast
  • Cancer - Metastatic
The purpose of this study is to compare existing treatment with any effects of receiving 1 year of treatment with pembrolizumab after surgery.
  • Cancer - Breast
A study to determine if the addition of atezolizumab to chemotherapy improves response in the breast and lymph nodes in patients with triple-negative…
  • Cancer - Breast